Changes in Beneficial Ownership · 4
Context Therapeutics Inc.
CNTXNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1782505299.xml
Filing details
- Report period
- 2026-06-24
- Issuer
- Context Therapeutics Inc.
- Issuer CIK
- 0001842952
- Trading symbol
- CNTX
Reporting owner 1
- Name
- Stacey Jennifer Evans
- Reporting owner CIK
- 0001321326
- Relationship
- Director
- Address
- 2001 MARKET STREET, SUITE 3915, UNIT #15, PHILADELPHIA, PA, 19103
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | 0.576 | 2026-06-24 | A · Form 4 | 45,000 | A | 0 | [F1] | 2036-06-23 | Common Stock | 45,000 | 45,000 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer.↩ 1
Signature 1
- Signed
- /s/ Alex Levit, Attorney-in-Fact
- Date
- 2026-06-26